Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
4.700
-0.070 (-1.47%)
Streaming Delayed Price
Updated: 1:53 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AtaiBeckley Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up
↗
April 21, 2026
Via
Chartmill
Why AtaiBeckley Stock Surged Today
↗
April 20, 2026
President Trump wants to fast-track psychedelic research.
Via
The Motley Fool
Topics
Government
This 4/20, Wall Street Is Betting on More Than Marijuana
↗
April 20, 2026
Via
MarketBeat
AtaiBeckley Stock Skyrockets After Cantor Fitzgerald's Overweight Rating
↗
April 20, 2026
AtaiBeckley (NASDAQ:ATAI) shares are surging Monday as psychedelic biotechs rally on President Trump's executive order to fast-track reviews.
Via
Benzinga
Topics
Government
What's going on in today's session
↗
April 20, 2026
Via
Chartmill
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
↗
April 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders.
Via
The Motley Fool
Topics
Government
These stocks are gapping in today's session
↗
April 20, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 20, 2026
Via
Chartmill
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
March 26, 2026
Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more...
Via
Finterra
Topics
Cannabis
Initial Public Offering
Intellectual Property
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
↗
January 19, 2026
Via
MarketBeat
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment
↗
January 05, 2026
GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression.
Via
Stocktwits
MarketBeat’s Top 5 Rated Small-Cap Stocks
↗
December 22, 2025
Via
MarketBeat
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order
↗
December 19, 2025
Jefferies sees restrictions around non-recreational psychedelics eventually loosen up.
Via
Stocktwits
Topics
Cannabis
ETFs
Government
Analyst Expectations For ATAI Life Sciences's Future
↗
October 22, 2025
Via
Benzinga
Why Atai Life Sciences Stock Was So Lively This Week
↗
October 17, 2025
The company, which focuses on psychedelic-based medicine, had a busy few days on both the regulatory and financing fronts.
Via
The Motley Fool
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
October 14, 2025
As of mid-October 2025, a compelling and diverse group of companies, spanning utilities, biotechnology, advanced materials, and defense, have seen their stocks reach impressive 52-week highs. This...
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
↗
October 13, 2025
Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion sales by 2035.
Via
Benzinga
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
↗
September 24, 2025
Via
Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
↗
September 23, 2025
Via
Benzinga
Why Atai Life Sciences Stock Crushed It on Tuesday
↗
September 23, 2025
Investors cheered good news from the lab delivered by the company.
Via
The Motley Fool
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
↗
September 23, 2025
Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 trials expected in 2026.
Via
Benzinga
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
↗
September 18, 2025
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
Via
Benzinga
Topics
Artificial Intelligence
Atai Life Sciences Revenue Jumps 163%
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
July 30, 2025
Via
Benzinga
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
↗
July 29, 2025
Via
Benzinga
Why Is ATAI Life Sciences Stock Trading Lower On Monday?
↗
July 28, 2025
Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a favorable safety profile.
Via
Benzinga
What's going on in today's pre-market session
↗
July 28, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via
Chartmill
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 28, 2025
Via
Benzinga
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus
↗
July 28, 2025
U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.
Via
Benzinga
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
↗
July 28, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
